4114 logo

Synmosa Biopharma Corporation Stock Price

TPEX:4114 Community·NT$16.1b Market Cap
  • 0 Narratives written by author
  • 0 Comments on narratives written by author
  • 0 Fair Values set on narratives written by author

4114 Share Price Performance

NT$32.15
1.15 (3.70%)
NT$32.15
1.15 (3.70%)
Price NT$32.15

4114 Community Narratives

There are no narratives available yet.

Trending Discussion

Updated Narratives

No recently updated narratives available.

Snowflake Analysis

Excellent balance sheet with acceptable track record.

0 Risks
1 Reward

Synmosa Biopharma Corporation Key Details

NT$6.1b

Revenue

NT$3.5b

Cost of Revenue

NT$2.7b

Gross Profit

NT$1.9b

Other Expenses

NT$769.9m

Earnings

Last Reported Earnings
Sep 30, 2025
Next Reporting Earnings
n/a
1.54
43.41%
12.60%
27.5%
View Full Analysis

About 4114

Founded
1970
Employees
n/a
CEO
Chih-Hui Lin
WebsiteView website
www.synmosa.com.tw

Synmosa Biopharma Corporation, a specialty pharmaceutical company, researches, develops, manufactures, markets, and distributes pharmaceutical and healthcare products under the Synmosa brand in Taiwan. The company offers its products in various therapeutic areas, including cardiovascular, respiratory, urology, sex hormone, and oncology. The company also provides its products in various forms, such as effervescent tablets, granules, nasal sprays, metered dosed inhalers, sex hormones, and other forms. In addition, it offers contract manufacturing services. The company also exports its products to South Africa, China, Hong Kong, Thailand, Singapore, Malaysia, and other countries. Synmosa Biopharma Corporation was founded in 1970 and is based in Taipei, Taiwan.

Recent 4114 News & Updates

Recent updates

No updates